Nissim Benvenisty, MD, PhD
The Hebrew University of Jerusalem, Israel

Robert Blelloch, MD, PhD
University of California, San Francisco, USA

Daniel Marshak, PhD
Consulting & Advisory, USA

Melissa Carpenter, PhD
ElevateBio, USA

Assem Ziady, PhD
Cincinnati Children’s Hospital Medical Center, USA

John Tisdale, MD

Shen Shen, PhD
Biogen, USA

Gerhard Bauer, Professor
University of California, School of Medicine, USA


The International Society for Stem Cell Research (ISSCR) and the American Society of Gene and Cell Therapy (ASGCT) are partnering to host a cutting-edge program on the latest advances in regenerative medicine. 

Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies. World-renowned scientists will share their latest advances in three focused two-hour virtual sessions on: Neural Disorders, Cell & Gene Therapy Manufacturing Technologies, and Hematopoietic Diseases and Immuno-Oncology. Join us for this outstanding program of international leaders in gene and cell therapies.

For information on sponsorship opportunities, please email


Program 1: Neural Disorders
13 September 2021
10:00 - 12:00 EDT (view your time zone)

Neural disorders are among the leading targets for gene and cell therapies. Recent advances in the differentiation of stem cell-derived neural cell types and gene editing technologies are enabling new potential therapies for devastating diseases of the nervous system. Hear from world-renowned experts who are uncovering new mechanisms of diseases including Huntington’s Disease, Parkinson’s Disease, Tauopathies, and Myotonic Dystrophy, and pioneering the development of experimental new therapies. This program will be moderated by Melissa Carpenter, PhD and Assem Ziady, PhD. Read the program newsletter.

Leslie Thompson, PhD
UC Irvine, USA
Malin Parmar, PhD
Lund University, Sweden
Gene Yeo, PhD, MBA
UC San Diego, USA
Sally Temple, PhD
Neural Stem Cell Institute, USA

Program 2: Cell & Gene Therapy Manufacturing
14 September 2021
10:00 - 12:00 EDT (view your time zone)
Innovation Showcase By:
Mission Bio

Scaling-up or scaling-out cell and gene therapy products remains an active challenge for the field of regenerative medicine. Program 2 focuses on the latest technologies and strategies to address concerns and accelerate the manufacturing of scalable, safe, and effective cell and gene therapies. This program will be moderated by Gerhard Bauer and Shen Shen, PhD. Read the program newsletter.

Mohamed Abou El-Enein, MD, PhD
University of Southern California, USA
Thomas VanCott, PhD
Catalent Cell & Gene Therapy, USA
Melissa Carpenter Headshot
Melissa Carpenter, PhD
ElevateBio, USA
John Pierciey, MS
bluebird bio, USA

Program 3: Hematopoietic Diseases and Immuno-Oncology
15 September 2021
10:00 - 12:00 EDT (view your time zone)

Program 3 focuses on emerging therapies involving the blood – as both treatment target and therapeutic tool. Hear about the latest developments using gene therapies to treat blood disorders and the next generation of hematopoietic stem cell and iPSC-derived CAR-T and natural killer cell immunotherapies for treating a variety of cancers. This program will be moderated by John Tisdale, MD and Robert Blelloch, MD, PhD. Read the program newsletter.

Hans-Peter Kiem, MD, PhD
Fred Hutchinson Cancer Center, USA
Simón Méndez-Ferrer, PhD
University of Cambridge, UK
Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center, USA
Bob Valamehr, PhD
Fate Therapeutics, USA